Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corp (BCPC) delivers specialty performance ingredients for nutrition and industrial markets through advanced technologies. This news hub provides investors and industry professionals with essential updates on corporate developments and market leadership.
Access authoritative reporting on earnings announcements, product innovations, and strategic partnerships. Our curated collection ensures you stay informed about BCPC's advancements in microencapsulation techniques and chelation technology across human/animal nutrition sectors.
Discover press releases detailing regulatory milestones, manufacturing expansions, and sustainability initiatives. All content is verified for accuracy, offering neutral analysis without speculative commentary.
Bookmark this page for real-time access to Balchem's financial disclosures and operational updates. Regularly refreshed content supports informed decision-making for stakeholders tracking specialty chemical markets.
Balchem (NASDAQ: BCPC) reported strong Q1 2025 financial results with record net sales of $250.5 million, up 4.5% year-over-year. The company achieved net earnings of $37.1 million, a 27.8% increase, and record adjusted EBITDA of $66.3 million, up 8.9% from the prior year quarter.
All three segments - Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products - showed sales and earnings growth. The Human Nutrition segment led with record sales of $158.5 million, while gross margin improved to 35.2%, up 120 basis points. Operating expenses decreased to $37.2 million, and free cash flow was $31.0 million.
The company maintains a strong financial position with $49.9 million in cash and continues to invest in growth initiatives despite global trade uncertainties.
Balchem (NASDAQ: BCPC) has released its 2024 Sustainability Report, highlighting significant progress in environmental and social initiatives. The company has exceeded its 2030 greenhouse gas emissions reduction target, achieving a 32% reduction from the 2020 baseline, surpassing the original 25% goal.
Key achievements include:
- Approximately 70% of revenue supports UN Sustainable Development Goals
- 15% reduction in water withdrawal compared to 2020 baseline
- Improved safety metrics with TRIR at 0.57 and LTIR at 0.21
- Fourth anniversary of commitment to UN Global Compact
CEO Ted Harris emphasized Balchem's dual focus on providing innovative health and nutritional solutions while maintaining excellence in stewarding people, communities, and shareholders. The company remains aligned with UN SDGs focusing on zero hunger, good health and well-being, and responsible consumption and production.
Balchem (NASDAQ: BCPC) has scheduled its first quarter 2025 financial results conference call for Thursday, April 24, 2025, at 11:00 AM Eastern Time. The event will be hosted by Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO.
The Q1 2025 results will be released before market opening on April 24, 2025, with the press release and financial exhibits available on www.balchem.com. Investors can join the call via toll-free number 1-877-407-8289 or local dial-in 1-201-689-8341.
A replay of the conference call will be accessible for three hours after conclusion until May 8, 2025, using dial-in numbers 1-877-660-6853 (toll-free) or 1-201-612-7415 (local) with conference ID #13753034.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer focusing on health and nutrition markets, has announced its participation in the BNP Paribas Exane 13th Consumer Ingredients Conference scheduled for March 11, 2025.
The company will be represented by Ted Harris, Chairman of the Board, Chief Executive Officer, and President, along with Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations.
The announcement was made from Montvale, N.J. on February 25, 2025. This conference represents an opportunity for Balchem to engage with industry participants and potentially share insights about their operations in the specialty ingredient manufacturing sector.
Balchem (NASDAQ: BCPC) reported strong Q4 2024 financial results with record net sales of $240.0 million, up 4.9% year-over-year. The company achieved net earnings of $33.6 million, a 26.0% increase, and record adjusted EBITDA of $62.8 million, up 13.4%.
For full-year 2024, Balchem delivered record net sales of $953.7 million, a 3.4% increase, with GAAP net earnings of $128.5 million (+18.4%). The company generated strong cash flows from operations of $182.0 million and free cash flow of $147.2 million, enabling debt reduction of $119.6 million.
All three segments showed growth, with Human Nutrition & Health leading at $147.3 million (+6.8%), Animal Nutrition & Health at $58.3 million (+0.3%), and Specialty Products at $32.9 million (+6.0%). Gross margin improved to 36.0%, up 320 basis points from the prior year.
Balchem (NASDAQ: BCPC) has scheduled a conference call for Friday, February 21, 2025, at 11:00 AM Eastern Time to discuss its fourth quarter and full year 2024 financial results. The call will be hosted by Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO.
The company will release its financial results before the market opens on February 21, 2025. The press release and financial exhibits will be available on Balchem's website. Investors can join the call by dialing toll-free 1-877-407-8289 or 1-201-689-8341 locally. A replay will be available for three hours after the call until March 7, 2025, accessible by dialing 1-877-660-6853 or 1-201-612-7415 with conference ID #13751680.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer focusing on health and nutrition markets, has announced its participation in the upcoming CJS Securities New Ideas for the New Year Virtual Conference. The presentation is scheduled for January 14, 2025.
The company will be represented by Ted Harris (Chairman of the Board, President and Chief Executive Officer), Martin Bengtsson (Chief Financial Officer), and Allison Baurichter (Senior Director Investor Relations) at the conference.
Balchem (NASDAQ: BCPC) has declared a dividend of $0.87 per share on its common stock, payable on January 17, 2025, to stockholders of record as of December 26, 2024. This represents a 10.1% increase compared to the previous year's annual dividend. The announcement marks Balchem's sixteenth consecutive annual dividend increase, reflecting the company's consistent financial performance and the Board's confidence in their long-term strategies.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer focusing on health and nutrition markets, has announced its participation at Baird's 54th Annual Global Industrial Conference on November 13, 2024. The company will be represented by Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) at the presentation.
Balchem (NASDAQ: BCPC) reported strong third quarter 2024 financial results with net sales of $239.9 million, up 4.3% year-over-year. The company achieved record earnings from operations and adjusted EBITDA of $64.4 million, a 7.6% increase. Net earnings rose 16.4% to $33.8 million, with earnings per share of $1.03. The Human Nutrition and Health segment showed excellent performance with 5.4% sales growth, while Specialty Products grew 10.6%. Cash flows from operations were $51.3 million, with quarterly free cash flow of $42.2 million. The company's net debt decreased to $153.3 million with a leverage ratio of 0.6 times.
